UMass Medical School is developing strategies to more efficiently manage Hepatitis C treatment at a time when both new infections and the cost of new, life-saving drugs are soaring, says Pavel Lavitas, PharmD, BCPS, of UMass Medical School.
For state Medicaid programs and other health plans, keeping up with the dramatic progress in new Hepatitis C drugs and treatment can be a major challenge, says UMass Medical School pharmacist Pavel Lavitas, PharmD, BCPS.
Hepatitis C is one of the top public health challenges facing the U.S., with as many as three to four million people currently living with this “chronic infection,” notes Pavel Lavitas, PharmD, BCPS, of UMass Medical School.
Pairing patients up with the right medications, sending refill reminders and tracking results are all ingredients for a successful hepatitis C medication management program, says UMass Medical School pharmacy expert.
